Tesaro execs split $304M windfall from $5.1B GlaxoSmithKline buyout
Tesaro CEO Lonnie Moulder may not have landed the deal he originally wanted for selling the biotech, but he’s not exactly coming away empty-handed.
As part of their detailed look back at the deal, the biotech also revealed that Moulder will receive a total of $155,854,551 for his stock, options and RSU grant. President Mary Lynne Hedley gets $112,500,429.
That’s all substantially better than the rest of the executive crew, each of whom gets millions. Here’s the full roster from the SEC filing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.